Brexpiprazole Tablets Suppliers & Bulk Manufacturers
Available Forms: Tablets
Available Strengths: 0.25 mg, 0.5 mg, 1 mg, 2 mg, 3 mg, 4 mg
Reference Brands: Rexulti®(US & EU)
Category: Psychiatry / Mental Health
Brexpiprazole is an atypical antipsychotic that acts as a partial agonist at dopamine D2 and serotonin 5-HT1A receptors and an antagonist at 5-HT2A receptors. This balanced activity helps modulate dopamine and serotonin pathways in the brain. It is used for the treatment of schizophrenia and as an adjunctive therapy for major depressive disorder (MDD) in adults, offering improved mood stabilization and reduced psychotic symptoms with a lower risk of extrapyramidal side effects.
Manufacture or export Brexpiprazole Tablets? List it or send an offer →
Product Description:
Brexpiprazole tablets are FDA-approved in the United States for the treatment of schizophrenia and as an adjunctive therapy for major depressive disorder (MDD) in adults. In the European Union, Brexpiprazole is approved under brand names like Rxulti, primarily for schizophrenia, following centralized EMA procedures. Regulatory compliance includes GMP standards, comprehensive clinical data, and documentation on metabolic side effects, akathisia, and suicidality risks. U.S. submissions must meet FDA requirements including boxed warnings for elderly dementia-related psychosis. EMA approval mandates a full Risk Management Plan (RMP) and pharmacovigilance commitments.
Also known as: brexpiprazol (Spanish, Portuguese), brexpiprazole (French), Brexpiprazol (German), brexpiprazolo (Italian), brekspiprazol (Turkish, Indonesian), брекспипразол (Russian), بريكسبيبريزول (Arabic), 布瑞哌唑 (Chinese), ブレクスピプラゾール (Japanese).
Brexpiprazole Tablets — third party manufacturing & bulk supply
Brexpiprazole Tablets is available through PharmaTradz for wholesale and bulk supply as well as on a third party (contract) manufacturing basis. Buyers sourcing this product generally take one of three routes:
Indicative minimum order quantity
Brexpiprazole Tablets is supplied as Tablets — an oral solid dosage form, so the indicative MOQ is 200,000 units. Actual MOQ is confirmed by the allocated manufacturer against your pack presentation and destination market. See full supply terms for dossier formats, market availability and shelf life.
Manufacturers of Brexpiprazole Tablets listed on PharmaTradz hold site-level approvals across WHO-GMP, EU-GMP, USFDA, ANVISA and TGA, verified at onboarding.
Request a quote for Brexpiprazole Tablets →Usually answered within 48 hours, with matched manufacturers, indicative prices and document status.
Frequently Asked Questions
Brexpiprazole is used to treat psychiatric conditions such as schizophrenia and as an adjunct therapy for major depressive disorder. It helps improve mood, reduce psychotic symptoms, and enhance overall functioning in patients with mental health disorders.
Brexpiprazole is a synthetic pharmaceutical compound that acts as a serotonin–dopamine activity modulator. It is manufactured under controlled pharmaceutical processes to ensure purity, stability, and consistent therapeutic effects.
Brexpiprazole is marketed under the brand name Rexulti in the United States and other regions.
Brexpiprazole (Rexulti) is manufactured and marketed by Otsuka Pharmaceutical Co., Ltd. in partnership with other authorized distributors depending on the region.
The generic name is Brexpiprazole.
The most recognized brand name is Rexulti.
Brexpiprazole is manufactured in regulated pharmaceutical facilities that comply with international quality standards, including sites in the United States, Japan, and other regions where the product is approved for use.
El brexpiprazol es un antipsicótico atípico aprobado para el tratamiento de la esquizofrenia en adultos y, en algunos países, también como tratamiento complementario del trastorno depresivo mayor y para la agitación asociada a la demencia por enfermedad de Alzheimer. Es un medicamento de prescripción que se usa bajo supervisión médica, habitualmente de un psiquiatra. PharmaTradz permite a importadores, distribuidores y hospitales con licencia abastecerse de brexpiprazol en comprimidos de fabricantes con certificación GMP.
O brexpiprazol é um antipsicótico atípico aprovado para o tratamento da esquizofrenia em adultos e, em alguns países, também como tratamento adjuvante do transtorno depressivo maior e para a agitação associada à demência da doença de Alzheimer. É um medicamento de prescrição, usado sob supervisão médica, geralmente de um psiquiatra. A PharmaTradz permite que importadores, distribuidores e hospitais licenciados adquiram brexpiprazol em comprimidos de fabricantes com certificação GMP.
Le brexpiprazole est un antipsychotique atypique autorisé dans le traitement de la schizophrénie chez l’adulte et, dans certains pays, comme traitement d’appoint du trouble dépressif majeur et pour l’agitation associée à la démence de la maladie d’Alzheimer. C’est un médicament sur ordonnance, utilisé sous surveillance médicale, le plus souvent celle d’un psychiatre. PharmaTradz permet aux importateurs, distributeurs et hôpitaux agréés de s’approvisionner en brexpiprazole en comprimés auprès de fabricants certifiés BPF (GMP).
Related Products
Vortioxetine Film-Coated Tablets
Strength:
5 mg, 10 mg, 15 mg(EU only), 20 mg
Form: Film-Coated Tablets
Reference Brands: Trintellix®(US); Brintellix®(EU)
View DetailsVilazodone Film-Coated Tablets
Strength:
10 mg, 20 mg, 40 mg
Form: Film-Coated Tablets
Reference Brands: Viibryd(US)
View DetailsBupropion SR/ ER Tablets
Strength:
100 mg, 150 mg, 200 mg (SR); 150 mg, 300 mg (XL)
Form: Sustained-Release (SR) Tablets, Extended-Release (XL) Tablets
Reference Brands: Wellbutrin® SR/XL(US); Zyban®(EU & US)
View DetailsLevomilnacipran Extended-Release Capsules
Strength:
20 mg, 40 mg, 80 mg, 120 mg
Form: Extended-Release Capsules
Reference Brands: Fetzima®(US)
View DetailsMirtazapine 7.5mg Tablet
Strength:
7.5 mg, 15 mg, 30 mg, 45 mg
Form: Tablets
Reference Brands: Zispin (EU)
View DetailsClonazepam Tablets/ODT
Strength:
0.25 mg, 0.5 mg, 1 mg, 2 mg
Form: Tablets/ODT
Reference Brands: US: Klonopin®; EU: Rivotril®
View DetailsClonazepam Oral Solution
Strength:
2.5 mg/mL
Form: Oral Solution
Reference Brands: US: Klonopin®; EU: Rivotril®
View DetailsDesvenlafaxine Extended-Release Tablets
Strength:
25 mg, 50 mg, 100 mg
Form: Extended-Release Tablets
Reference Brands: Pristiq®(US & EU)
View DetailsUsually answered within 48 hours | GMP documents shared before you commit